Revagenix website screenshot

Revagenix

Revagenix, Inc. is a private clinical-stage precision-therapeutics company headquartered in San Francisco, California, founded in 2019 by antibacterial-discovery veterans from Achaogen. The company takes a first-principles approach to drug design for serious chronic disease, engineering each candidate around target biology, route of delivery and tolerability. Its lead program, Rev-56, is a first-in-class inhaled precision therapy with a novel mechanism of action targeting chronic Pseudomonas infection in non-cystic-fibrosis bronchiectasis (NCFB), a progressive respiratory disease affecting an estimated 350,000 to 500,000 adults in the United States; Rev-56 is entering Phase 1 clinical development in 2026, with a dry-powder formulation approaching candidate selection. Revagenix is backed by Novo Holdings, Tenmile, the REPAIR Impact Fund and the National Institute of Allergy and Infectious Diseases (NIAID contract 75N93022C00061). Revagenix is a therapeutics developer, not a software vendor: it publishes no API, SDK, developer portal or machine-readable contract.

Revagenix is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Therapeutics.

Revagenix’s developer surface includes engineering blog, support, and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub
5.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesTherapeuticsAnti-InfectivesRespiratoryClinical StageDrug DiscoveryPrivate Company

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Composite quality — 5.5/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 1.2 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Surface 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/revagenix: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Revagenix Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 5

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 LinkedIn
LinkedIn
 Careers
Careers

Other 2

Properties that don't map to a standard resource type

Pipeline
Pipeline
 Team
Team

Source (apis.yml)

apis.yml Raw ↑ 
aid: revagenix
name: Revagenix
description: 'Revagenix, Inc. is a private clinical-stage precision-therapeutics company headquartered in San Francisco, California,
  founded in 2019 by antibacterial-discovery veterans from Achaogen. The company takes a first-principles approach to drug
  design for serious chronic disease, engineering each candidate around target biology, route of delivery and tolerability.
  Its lead program, Rev-56, is a first-in-class inhaled precision therapy with a novel mechanism of action targeting chronic
  Pseudomonas infection in non-cystic-fibrosis bronchiectasis (NCFB), a progressive respiratory disease affecting an estimated
  350,000 to 500,000 adults in the United States; Rev-56 is entering Phase 1 clinical development in 2026, with a dry-powder
  formulation approaching candidate selection. Revagenix is backed by Novo Holdings, Tenmile, the REPAIR Impact Fund and the
  National Institute of Allergy and Infectious Diseases (NIAID contract 75N93022C00061). Revagenix is a therapeutics developer,
  not a software vendor: it publishes no API, SDK, developer portal or machine-readable contract.'
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://cdn.prod.website-files.com/615238718d430c9069b2aa1f/6167c5a4be0897de151aaa5e_open-graph.png
url: https://raw.githubusercontent.com/api-evangelist/revagenix/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Therapeutics
- Anti-Infectives
- Respiratory
- Clinical Stage
- Drug Discovery
- Private Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/revagenix-domain-security.yml
- type: Website
  url: https://www.revagenix.com/
- type: About
  url: https://www.revagenix.com/company
- type: Pipeline
  url: https://www.revagenix.com/pipeline
- type: Team
  url: https://www.revagenix.com/team
- type: Blog
  url: https://www.revagenix.com/news
- type: Support
  url: https://www.revagenix.com/contact
- type: LinkedIn
  url: https://www.linkedin.com/company/revagenix-inc
- type: Careers
  url: https://www.linkedin.com/company/revagenix-inc/jobs/
- type: LLMsTxt
  url: llms/revagenix-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Revagenix is a 15-person clinical-stage biopharma whose product is Rev-56, an inhaled drug entering Phase 1 in 2026;
    its entire web presence is a six-page Webflow marketing site (company, pipeline, team, news, contact) with no developer
    section, no GitHub organization, and no api./docs./developer. subdomain in DNS.
  evidence:
  - url: https://www.revagenix.com/
    status: 200
  - url: https://www.revagenix.com/openapi.json
    status: 404
  - url: https://www.revagenix.com/.well-known/api-catalog
    status: 404
  - url: https://api.github.com/orgs/revagenix
    status: 404
  checked: '2026-08-26'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider 
curl "https://apis.io/api/v1/providers/revagenix"
All providers 
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose 
curl "https://apis.io/api/v1/providers/revagenix/operations?limit=25"
How their score was established 
curl "https://apis.io/api/v1/providers/revagenix/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.